Basic Research in Cardiology

, Volume 104, Issue 3, pp 307–320 | Cite as

Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure

  • Giampiero La Rocca
  • Antonino Di Stefano
  • Ermanno Eleuteri
  • Rita Anzalone
  • Francesca Magno
  • Simona Corrao
  • Tiziana Loria
  • Anna Martorana
  • Claudio Di Gangi
  • Marilena Colombo
  • Fabrizio Sansone
  • Francesco Patanè
  • Felicia Farina
  • Mauro Rinaldi
  • Francesco Cappello
  • Pantaleo Giannuzzi
  • Giovanni Zummo


Increased oxidative stress has been implicated in the pathogenesis of a number of cardiovascular diseases. Recent findings suggest that myeloperoxidase (MPO) may play a key role in the initiation and maintenance of chronic heart failure (CHF) by contributing to the depletion of the intracellular reservoir of nitric oxide (NO). NO consumption through MPO activity may lead to protein chlorination or nitration, leading to tissue damage. Primary cultures of human endocardial endothelial cells (EEC) obtained at heart transplantation of patients with CHF and human umbilical vein endothelial cells (HUVEC) were subjected to oxidative stress by incubation with hydrogen peroxide at non lethal (60 µM) dose for different exposure times (3 and 6 h). Treated and control cells were tested by immunohistochemistry and RT-PCR for MPO and 3-chlorotyrosine expression. Both endothelial cell types expressed myeloperoxidase following oxidative stress, with higher levels in EEC. Moreover, 3-chlorotyrosine accumulation in treated cells alone indicated the presence of MPO-derived hypochlorous acid. Immunohistochemistry on sections from post-infarcted heart confirmed in vivo the endothelial positivity to MPO, 3-chlorotyrosine and, to a minor extent, nitrotyrosine. Immunohistochemical observations were confirmed by detection of MPO mRNA in both stimulated EEC and HUVEC cells. This study demonstrates for the first time that EEC can express MPO after oxidative stress, both in vitro and in vivo, followed by accumulation of 3-chlorotyrosine, an end product of oxidative stress. Deregulation of endothelial functions may contribute to the development of a number of cardiovascular diseases, including CHF. The results also highlight the notion that endothelium is not only a target but also a key player in oxidative-driven cardiovascular stress.


3-chlorotyrosine endocardium endothelial cells myeloperoxidase oxidative stress 



We thank Rosemary Allpress for her revision of the English language. We thank Antonella Chiara, Santina Di Gangi and Giusy Scaduto for the valuable support during the experimental work. This work was supported by Fondazione S. Maugeri, IRCCS, Ricerca corrente, and Italian Ministry of University (Ex 60% to GZ, FC, FF) grants. The authors declare no conflict of interests.

Supplementary material

395_2008_761_MOESM1_ESM.jpg (100 kb)
ESM1 (JPEG 100 kb)
395_2008_761_MOESM2_ESM.jpg (87 kb)
ESM2 (JPEG 87 kb)
395_2008_761_MOESM3_ESM.jpg (3.5 mb)
ESM3 (JPEG 3,549 kb)
395_2008_761_MOESM4_ESM.doc (88 kb)
ESM4 (DOC 88 kb)


  1. 1.
    Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, Ma W, Tousson A, White CR, Bullard DC, Brennan ML, Lusis AJ, Moore KP, Freeman BA (2001) Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108:1759–1770PubMedGoogle Scholar
  2. 2.
    Baldus S, Heitzer T, Eiserich JP, Lau D, Mollnau H, Ortak M, Petri S, Goldmann B, Duchstein HJ, Berger J, Helmchen U, Freeman BA, Meinertz T, Munzel T (2004) Myeloproxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 37:902–911PubMedCrossRefGoogle Scholar
  3. 3.
    Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szoks K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, Heitzer T (2006) Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113:1871–1878PubMedCrossRefGoogle Scholar
  4. 4.
    Berry CE, Hare JM (2004) Xanthine oxidoreductase in the cardiovascular system: molecular mechanisms and pathophysiologic implications. J Physiol 555:589–606PubMedCrossRefGoogle Scholar
  5. 5.
    Bradley JR, Johnson DR, Pober JS (1993) Endothelial activation by hydrogen peroxide. Am J Pathol 142:1598–1609PubMedGoogle Scholar
  6. 6.
    Cai H (2005) Hydrogen peroxide regulation of endothelial function: Origin, mechanism and consequences. Cardiovasc Res 68:26–36PubMedCrossRefGoogle Scholar
  7. 7.
    Cappello F, Di Stefano A, David S, Rappa F, Anzalone R, La Rocca G, D’Anna SE, Magno F, Donner CF, Balbi B, Zummo G (2006) Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 107:2417–2424PubMedCrossRefGoogle Scholar
  8. 8.
    Chen X, Niroomand F, Liu Z, Zankl A, Katus HA, Jahn L, Tiefenbacher CP (2006) Expression of nitric oxide related enzymes in coronary heart disease. Basic Res Cardiol 101:346–353PubMedCrossRefGoogle Scholar
  9. 9.
    Clancy RM, Leszczynskapiziak J, Abramson SB (1992) Nitric-oxide, an endothelial-cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90:1116–1121PubMedCrossRefGoogle Scholar
  10. 10.
    Cote CG, Yu FS, Zulueta JJ, Vosatka RJ, Hassoun PM (1996) Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol Lung Cell Mol Physiol 15:L869–L874Google Scholar
  11. 11.
    Daugherty A, Dunn JL, Rateri DL, Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437–444PubMedCrossRefGoogle Scholar
  12. 12.
    Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG (2000) Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86:347–354PubMedGoogle Scholar
  13. 13.
    Eu JP, Hare JM, Hess DT, Skaf M, Sun J, Cordenas-Navina I, Sun QA, Dewhirst M, Meissner G, Stamler JS (2003) Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci USA 100:15229–15234PubMedCrossRefGoogle Scholar
  14. 14.
    Frantz S, Brandes RP, Hu K, Rammelt K, Wolf J, Scheuermann H, Ertl G, Bauersachs J (2006) Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX. Basic Res Cardiol 101:127–132PubMedCrossRefGoogle Scholar
  15. 15.
    Garcia SC, Pomblum V, Gams E, Langenbach MR, Schipke JD (2007) Independency of myocardial stunning of endothelial stunning? Basic Res Cardiol 102:359–367PubMedCrossRefGoogle Scholar
  16. 16.
    Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, Richter GM, Brennan ML, Lusis AJ, Belaaouaj A, Hotchkiss RS, Heinecke JW (2001) Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci USA 98:11961–11966PubMedCrossRefGoogle Scholar
  17. 17.
    Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500–508PubMedGoogle Scholar
  18. 18.
    Green PS, Mendez AJ, Jacob JS, Crowley JR, Growdon W, Hyman BT, Heinecke JW (2004) Neuronal expression of myeloperoxidase is increased in Alzheimer’s disease. J Neurochem 90:724–733PubMedCrossRefGoogle Scholar
  19. 19.
    Hare JM, Stamler JS (2005) NO/redox disequilibrium in the failing heart and cardiovascular system J Clin Invest 115:509–517PubMedGoogle Scholar
  20. 20.
    Hazen SL, Heinecke JW (1997) 3-Chlotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99:2075–2081PubMedCrossRefGoogle Scholar
  21. 21.
    Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 52:2745–2756PubMedCrossRefGoogle Scholar
  22. 22.
    Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SD, Tejani AD, Li D, Berkowitz DE, Hare JM (2004) Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci USA 101:15944–15948PubMedCrossRefGoogle Scholar
  23. 23.
    Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598–625PubMedCrossRefGoogle Scholar
  24. 24.
    Kumar AP, Piedrafita FJ, Reynolds WF (2004) Peroxisome proliferator-activated receptor γ ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the –463GA promoter polymorphism. J Biol Chem 279:8300–8315PubMedCrossRefGoogle Scholar
  25. 25.
    La Rocca G, Anzalone R, Magno F, Farina F, Cappello F, Zummo G (2007) Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts. Resp Res 8:23CrossRefGoogle Scholar
  26. 26.
    Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201–1209PubMedGoogle Scholar
  27. 27.
    Lau D, Baldus S (2006) Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111:16–26PubMedCrossRefGoogle Scholar
  28. 28.
    Linke A, Recchia F, Zhang X, Hintze TH (2003) Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev 8:87–97PubMedCrossRefGoogle Scholar
  29. 29.
    Liu X, Zweier JL (2001) A real-time electrochemical technique for measurement of cellular hydrogen peroxide generation and consumption: evaluation in human polymorphonuclear leukocytes. Free Radic Biol Med 31:894–901PubMedCrossRefGoogle Scholar
  30. 30.
    Maciag T, Hoover GA, Stemerman MB, Weinstein R (1981) Serial propagation of human endothelial cells in vitro. J Cell Biol 91:420–426PubMedCrossRefGoogle Scholar
  31. 31.
    Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P (2001) Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods 254:183–190PubMedCrossRefGoogle Scholar
  32. 32.
    Moens AL, Kass DA (2006) Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 26:2439–2444PubMedCrossRefGoogle Scholar
  33. 33.
    Nicholls SJ, Hazen SL (2005) Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102–1111PubMedCrossRefGoogle Scholar
  34. 34.
    Nie H, Wu JL, Zhang M, Xu J, Zou MH (2006) Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo. Diabetes 55:3133–3141PubMedCrossRefGoogle Scholar
  35. 35.
    Podrez EA, Abu-Soud HM, Hazen SL (2000) Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28:1717–1725PubMedCrossRefGoogle Scholar
  36. 36.
    Ricciardolo F, Caramori G, Ito K, Capelli A, Brun P, Abatangelo G, Papi A, Chung KF, Adcock I, Barnes PJ, Donner CF, Rossi A, Di Stefano A (2005) Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol 115:779–785PubMedCrossRefGoogle Scholar
  37. 37.
    Roy S, Khanna S, Sehn CK (2008) Redox regulation of the VEGF signaling path and tissue vascularization: Hydrogen peroxide, the common link between physical exercise and cutaneous wound healing. Free Rad Biol Med 44:180–192PubMedCrossRefGoogle Scholar
  38. 38.
    Salavej P, Spalteholz H, Arnhold J (2006) Modification of amino acid residues in human serum albumin by myeloperoxidase. Free Radic Biol Med 40:516–525PubMedCrossRefGoogle Scholar
  39. 39.
    Shinyashiki M, Pan CJG, Lopez BE, Fukuto JM (2004) Inhibition of the yeast metal reductase heme protein Fre1 by nitric oxide (NO): A model for inhibition of NADPH oxidase by NO. Free Radic Biol Med 37:713–723PubMedCrossRefGoogle Scholar
  40. 40.
    Stilli D, Lagrasta C, Berni R, Bocchi L, Savi M, Delucchi F, Graiani G, Monica M, Maestri R, Baruffi S, Rossi S, Macchi E, Musso E, Quaini F (2007) Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. Basic Res Cardiol 102:488–499PubMedCrossRefGoogle Scholar
  41. 41.
    Sugiyama S, Okada Y, Sukhova GK, Birmani R, Heinecke JW, Libby P (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-simulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879–891PubMedGoogle Scholar
  42. 42.
    Suhara T, Fukuo K, Sugimoto T, Morimoto S, Nakahashi T, Hata S, Shimizu M, Ogihara T (1998) Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol 160:4042–4047PubMedGoogle Scholar
  43. 43.
    Tang WHW, Brennan M-L, Philip K, Tong W, Mann S, Van Lente F, Hazen SL (2006) Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 98:796–799PubMedCrossRefGoogle Scholar
  44. 44.
    Thomas SR, Chen K, Keaney, JF Jr (2002) Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277:6017–6024PubMedCrossRefGoogle Scholar
  45. 45.
    Tiruppathi C, Naqvi T, Wu Y, Vogel SM, Minshall RD, Malik AB (2004) Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. Proc Natl Acad Sci USA 101:7699–7704PubMedCrossRefGoogle Scholar
  46. 46.
    Van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE (1999) Reactive nitrogen species and tyrosine nitration in the respiratory tract. epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 160:1–9PubMedGoogle Scholar
  47. 47.
    Vita JA, Brennan ML, Goke N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JF Jr, Hazen SL (2004) Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 110:1134–1139PubMedCrossRefGoogle Scholar
  48. 48.
    Winterbourn CC, Kettle AJ (2000) Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic Biol Med 5:403–409CrossRefGoogle Scholar
  49. 49.
    Zhen J, Lu H, Wang XQ, Vaziri ND, Zhou XJ (2008) Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 21:28–34PubMedCrossRefGoogle Scholar
  50. 50.
    Zou MH (2007) Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82:119–127PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2008

Authors and Affiliations

  • Giampiero La Rocca
    • 1
  • Antonino Di Stefano
    • 2
  • Ermanno Eleuteri
    • 3
  • Rita Anzalone
    • 1
  • Francesca Magno
    • 1
  • Simona Corrao
    • 1
  • Tiziana Loria
    • 1
  • Anna Martorana
    • 4
  • Claudio Di Gangi
    • 5
  • Marilena Colombo
    • 2
  • Fabrizio Sansone
    • 6
  • Francesco Patanè
    • 6
  • Felicia Farina
    • 1
  • Mauro Rinaldi
    • 6
  • Francesco Cappello
    • 1
  • Pantaleo Giannuzzi
    • 3
  • Giovanni Zummo
    • 1
  1. 1.Sezione di Anatomia Umana, Dipto. di Medicina SperimentaleUniversità degli Studi di PalermoPalermoItaly
  2. 2.Laboratorio di Citoimmunopatologia Apparato Cardio-RespiratorioFondazione S. Maugeri, IRCCSVerunoItaly
  3. 3.Divisione di CardiologiaFondazione S. Maugeri, IRCCSVerunoItaly
  4. 4.Dipto. di Patologia UmanaUniversità degli Studi di PalermoPalermoItaly
  5. 5.Istituto di Ostetricia e GinecologiaUniversità degli Studi di PalermoPalermoItaly
  6. 6.Divisione di CardiochirurgiaOspedale S. Giovanni BattistaTurinItaly

Personalised recommendations